We use cookies on our website to provide you with a better service.
More info
Accept all
More options
Functional cookies
Language cookie
Performance cookies
Google Analytics
YouTube
Vimeo
More info
Accept all
Ok
screenreader.back to home
screenreader.open offcanvas menu
Portfolio
Team
News
Contact
back to Capricorn Partners
Capricorn Health
News
rss feed
News
Stay up to date
year
by year
2023
2022
2021
2020
2019
2018
2017
reset
2021
Hologic acquires European Molecular diagnostic company Diagenode for approximately $159 million
1 March 2021
Mainstay Medical announces US$ 108 million equity financing transaction
16 February 2021
New study presents impressive results of Nexstim SmartFocus® nTMS Language Mapping
13 January 2021
2020
iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial
16 November 2020
Confo Therapeutics announces selection of first product candidate and initiation of pre-clinical development
15 October 2020
Nexstim continues to report promising results in quickly growing number of patients completing SmartFocus® rTMS treatment of Major Depressive Disorder
5 October 2020
Positive outcomes for iSTAR Medical’s MIGS MINIject shown in trials of over 130 glaucoma patients
29 September 2020
Mainstay Medical announces US FDA approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain
22 June 2020
Confo Therapeutics expands Board with appointment of Rob Scott as Independent Director
10 June 2020
Mainstay Medical announces reimbursement approval for ReActiv8 in Australia
8 June 2020
Confo Therapeutics appoints Paolo Vicini as Chief Development Officer
3 June 2020
iSTAR Medical announces outstanding results with MIGS implant
29 April 2020
1
2
3
4
5